Founded by former Inteliquet CEO Carla Balch, the firm is building on visualization technology to help physicians incorporate MDx testing into their practice.
The company announced the launch of the new products in the US and Europe as part of a product portfolio it has named Panther Scalable Solutions.
The diagnostic firms were the final companies in the coverage universe of 360Dx to present at the annual conference.
The Finnish biotechnology firm also announced plans to raise up to €80 million in the coming year.
Due out in December, the Magnis automated library prep instrument is meant to be an affordable and easy way for researchers to use Agilent's SureSelect kits.
The firm is looking to expand its sales internationally, as well as in the consumer-initiated market, but is being conservative with revenue growth estimates.
The company's goal is to serve what it sees as a massive but underaddressed target group: Asian women.
The German firm said that IB10 Sphingotec DPP3 is the first CE-IVD-marked point-of-care biomarker test that can quantify DPP3 blood plasma levels.
Illumina plans to upgrade all its NIPT customers to version 2 of its VeriSeq solution over the next year.
The company formally debuted the DxA 5000 at EuroMedLab 2019 this week as management pointed to its importance in the rejuvenation to the firm's pipeline.